Skip to main content

Vaishnaw Akshay's Form 4 filing

Alnylam Pharmaceuticals, Inc. (ALNY) · filed Dec 23, 2021

Accession no.
0001735276-21-000097
Filed
Dec 23, 2021
Trade date
Dec 21-23, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market sales total $549.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vaishnaw AkshayCIK 0001458494Officer (President, R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 21, 2021Common StockAGrant or awardAcquired+5,417$0.00$016,632Direct
Dec 22, 2021Common StockFTax withholdingDisposed−2,415$189.13−$456,748.9514,217Direct
Dec 22, 2021Common StockFTax withholdingDisposed−1$190.50−$190.514,216Direct
Dec 22, 2021Common StockFTax withholdingDisposed−122$186.48−$22,750.5614,094Direct
Dec 23, 2021Common StockSSaleDisposed−124$186.22−$23,091.2813,970Direct
Dec 23, 2021Common StockSSaleDisposed−137$187.08−$25,629.9613,833Direct
Dec 23, 2021Common StockSSaleDisposed−130$187.35−$24,355.513,703Direct
Dec 23, 2021Common StockSSaleDisposed−127$188.26−$23,909.0213,576Direct
Dec 23, 2021Common StockSSaleDisposed−73$189.01−$13,797.7313,503Direct
Dec 23, 2021Common StockSSaleDisposed−8$189.18−$1,513.4413,495Direct
Dec 23, 2021Common StockSSaleDisposed−144$189.24−$27,250.5613,351Direct
Dec 23, 2021Common StockSSaleDisposed−144$190.02−$27,362.8813,207Direct
Dec 23, 2021Common StockSSaleDisposed−5$190.27−$951.3513,202Direct
Dec 23, 2021Common StockSSaleDisposed−73$190.33−$13,894.0913,129Direct
Dec 23, 2021Common StockSSaleDisposed−142$190.39−$27,035.3812,987Direct
Dec 23, 2021Common StockSSaleDisposed−125$190.86−$23,857.512,862Direct
Dec 23, 2021Common StockSSaleDisposed−1,000$191.45F4−$191,45011,862Direct
Dec 23, 2021Common StockSSaleDisposed−73$192.25−$14,034.2511,789Direct
Dec 23, 2021Common StockSSaleDisposed−126$193.37−$24,364.6211,663Direct
Dec 23, 2021Common StockSSaleDisposed−145$193.67−$28,082.1511,518Direct
Dec 23, 2021Common StockSSaleDisposed−303$195.11F5−$59,118.3311,215Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Sale prices ranged from $191.14 to $191.80.

Referenced by the price of 1 transaction in Table I.

F5

Sale prices ranged from $194.82 to $195.43.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)